Mdt1 facilitates efficient repair of blocked DNA double-strand breaks and recombinational maintenance of telomeresv

被引:15
作者
Pike, Brietta L.
Heierhorst, Joerg
机构
[1] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1128/MCB.00471-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA recombination plays critical roles in DNA repair and alternative telomere maintenance. Here we show that absence of the SQ/TQ cluster domain-containing protein Mdt1 (Ybl051c) renders Saccharomyces cerevisiae particularly hypersensitive to bleomycin, a drug that causes 3'-phospho-glycolate-blocked DNA double-strand breaks (DSBs). mdt1 Delta also hypersensitizes partially recombination-defective cells to camptothecin-induced 3'-phospho-tyrosyl protein-blocked DSBs. Remarkably, whereas mdt1 Delta cells are unable to restore broken chromosomes after bleomycin treatment, they efficiently repair "clean" endonuclease-generated DSBs. Epistasis analyses indicate that MDT1 acts in the repair of bleomycin-induced DSBs by regulating the efficiency of the homologous recombination pathway as well as telomere-related functions of the KU complex. Moreover, mdt1 Delta leads to severe synthetic growth defects with a deletion of the recombination facilitator and telomerepositioning factor gene CTF18 already in the absence of exogenous DNA damage. Importantly, mdt1 Delta causes a dramatic shift from the usually prevalent type II to the less-efficient type I pathway of recombinational telomere maintenance in the absence of telomerase in liquid senescence assays. As telomeres resemble protein-blocked DSBs, the results indicate that Mdt1 acts in a novel blocked-end-specific recombination pathway that is required for the efficiency of both drug-induced DSB repair and telomerase-independent telomere maintenance.
引用
收藏
页码:6532 / 6545
页数:14
相关论文
共 75 条
[1]   A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin [J].
Aouida, M ;
Pagé, N ;
Leduc, A ;
Peter, M ;
Ramotar, D .
CANCER RESEARCH, 2004, 64 (03) :1102-1109
[2]   The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle [J].
Aylon, Y ;
Liefshitz, B ;
Kupiec, M .
EMBO JOURNAL, 2004, 23 (24) :4868-4875
[3]   Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing [J].
Boulton, SJ ;
Jackson, SP .
EMBO JOURNAL, 1998, 17 (06) :1819-1828
[4]   Telomerase and ATM/Tel1p protect telomeres from nonhomologous end joining [J].
Chan, SWL ;
Blackburn, EH .
MOLECULAR CELL, 2003, 11 (05) :1379-1387
[5]   Bleomycins: Towards better therapeutics [J].
Chen, JY ;
Stubbe, J .
NATURE REVIEWS CANCER, 2005, 5 (02) :102-112
[6]   Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events [J].
Chen, QJ ;
Ijpma, A ;
Greider, CW .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1819-1827
[7]   Def1p is involved in telomere maintenance in budding yeast [J].
Chen, YB ;
Yang, CP ;
Li, RX ;
Zeng, R ;
Zhou, JQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :24784-24791
[8]   Inactivation of Ku-mediated end joining suppresses mec1Δ lethality by depleting the ribonucleotide reductase inhibitor Sml1 through a pathway controlled by Tel1 kinase and the Mre11 complex [J].
Corda, Y ;
Lee, SE ;
Guillot, S ;
Walther, A ;
Sollier, J ;
Arbel-Eden, A ;
Haber, JE ;
Géli, V .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (23) :10652-10664
[9]   Smc5p promotes faithful chromosome transmission and DNA repair in Saccharomyces cerevisiae [J].
Cost, GJ ;
Cozzarelli, NR .
GENETICS, 2006, 172 (04) :2185-2200
[10]   Shelterin: the protein complex that shapes and safeguards human telomeres [J].
de Lange, T .
GENES & DEVELOPMENT, 2005, 19 (18) :2100-2110